J Korean Soc Matern Child Health.  2020 Oct;24(4):196-203. 10.21896/jksmch.2020.24.4.196.

A Review on the Effects of Melatonin on Fetal Protection during Pregnancy with Intrauterine Inflammation

• Kim JM
• Lee JY

• KMID: 2508663
• DOI: http://doi.org/10.21896/jksmch.2020.24.4.196

Abstract

Intrauterine inflammation is defined as the inflammation of the chorion, amnion, and placenta. Untreated inflammation increases the risk of fetal inflammatory response syndrome, which may result in multiorgan diseases involving the brain, cardiovascular system, lung, eye, and intestine. Therefore, controlling inflammation is critical in pregnant women to reduce the risk of diseases. However, there are no safe and effective anti-inflammatory drugs for administration during pregnancy. Although the primary function of melatonin is to control circadian rhythms, it has protective effects against cellular insults occurring from hypoxia, oxidative stress, and inflammation. While animal studies support the effective and safe role of melatonin in improving pregnancy-related morbidities, it leaves plenty of opportunities for clinical studies investigating its anti-inflammatory, antioxidant, and protective effects against insults induced by intrauterine inflammation. Therefore, it will be worthwhile to investigate antenatal supplementation of melatonin in pregnant women with intrauterine inflammation to reduce the incidence of associated comorbidities.

Keyword

Melatonin; Intrauterine inflammation; Fetal injury; Preterm birth

Reference

Alghamdi BS. The neuroprotective role of melatonin in neurological disorders. J Neurosci Res. 2018. 96:1136–49.

Ambalavanan N., Carlo WA., D'Angio CT., McDonald SA., Das A., Schendel D, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009. 123:1132–41.

Balinotti JE., Chakr VC., Tiller C., Kimmel R., Coates C., Kisling J, et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med. 2010. 181:1093–7.

Bell MJ., Hallenbeck JM. Effects of intrauterine inflammation on developing rat brain. J Neurosci Res. 2002. 70:570–9.

Bosma KJ., Taneja R., Lewis JF. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome. Drugs. 2010. 70:1255–82.

Bourbon J., Boucherat O., Chailley-Heu B., Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res. 2005. 57:38–46.

Brzezinski A. Melatonin in Humans. N Engl J Med. 1997. 336:186–95.

Chen HY., Chen TY., Lee MY., Chen ST., Hsu YS., Kuo YL, et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res. 2006. 41:175–82.

Choi JY., Rha DW., Park ES. The effects of the severity of periventricular leukomalacia on the neuropsychological outcomes of preterm children. J Child Neurol. 2016. 31:603–12.

Chung SY., Han SH. Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. J Pineal Res. 2003. 34:95–102.

Claustrat B., Brun J., Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005. 9:11–24.

Collaco JM., McGrath-Morrow SA. Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more. Ann Am Thorac Soc. 2018. 15:530–8.

Collins JJP., Kallapur SG., Knox CL., Nitsos I., Polglase GR., Pillow JJ, et al. Inflammation in fetal sheep from intra-amniotic injection of Ureaplasma parvum. Am J Physiol Lung Cell Mol Physiol. 2010. 299:L852–60.

Deacon S., English J., Arendt J. Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans. Neurosci Lett. 1994. 178:32–4.

Deng WG., Tang ST., Tseng HP., Wu KK. Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood. 2006. 108:518–24.

Domínguez Rubio AP., Sordelli MS., Salazar AI., Aisemberg J., Bariani MV., Cella M, et al. Melatonin prevents experimental preterm labor and increases offspring survival. J Pineal Res. 2014. 56:154–62.

El Frargy M., El-sharkawy HM., Attia GF. Use of melatonin as an adjuvant therapy in neonatal sepsis. J Neonatal Perinatal Med. 2015. 8:227–32.

Eloundou SN., Lee J., Wu D., Lei J., Feller MC., Ozen M, et al. Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae. PLoS One. 2019. 14:e0214951.

Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005. 131:417–30.

Folkerth RD. Periventricular leukomalacia: overview and recent findings. Pediatr Dev Pathol. 2006. 9:3–13.

Gantert M., Been JV., Gavilanes AW., Garnier Y., Zimmermann LJ., Kramer BW. Chorioamnionitis: a multiorgan disease of the fetus? J Perinatol. 2010. 30:S21–30.

Gavilanes AW., Strackx E., Kramer BW., Gantert M., Van den Hove D., Steinbusch H, et al. Chorioamnionitis induced by intra-amniotic lipopolysaccharide resulted in an interval-dependent increase in central nervous system injury in the fetal sheep. Am J Obstet Gynecol. 2009. 200:437.e1–8.

Gitto E., Karbownik M., Reiter RJ., Tan DX., Cuzzocrea S., Chiurazzi P, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001. 50:756–60.

Gitto E., Reiter RJ., Amodio A., Romeo C., Cuzzocrea E., Sabatino G, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res. 2004a. 36:250–5.

Gitto E., Reiter RJ., Cordaro SP., La Rosa M., Chiurazzi P., Trimarchi G, et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol. 2004b. 21:209–16.

Gitto E., Reiter RJ., Sabatino G., Buonocore G., Romeo C., Gitto P, et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res. 2005. 39:287–93.

Goldenberg RL., Culhane JF., Iams JD., Romero R. Epidemiology and causes of preterm birth. Lancet. 2008. 371:75–84.

Gomez-Lopez N., Romero R., Arenas-Hernandez M., Panaitescu B., Garcia-Flores V., Mial TN, et al. Intra-amniotic administration of lipopolysaccharide induces spontaneous preterm labor and birth in the absence of a body temperature change. J Matern Fetal Neonatal Med. 2018. 31:439–46.

Graham HK., Rosenbaum P., Paneth N., Dan B., Lin JP., Damiano DL, et al. Cerebral palsy. Nat Rev Dis Primers. 2016. 2:15082.

Gravett MG., Witkin SS., Haluska GJ., Edwards JL., Cook MJ., Novy MJ. An experimental model for intra-amniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol. 1994. 171:1660–7.

Hagberg H., Mallard C., Ferriero DM., Vannucci SJ., Levison SW., Vexler ZS, et al. The role of inflammation in perinatal brain injury. Nat Rev Neurol. 2015. 11:192–208.

Higgins RD., Saade G., Polin RA., Grobman WA., Buhimschi IA., Watterberg K, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016. 127:426–36.

Hsu CN., Huang LT., Tain YL. Perinatal use of melatonin for offspring health: focus on cardiovascular and neurological diseases. Int J Mol Sci. 2019. 20:5681.

Husain AN., Siddiqui NH., Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998. 29:710–7.

Kallapur SG., Bachurski CJ., Cras TDL., Joshi SN., Ikegami M., Jobe AH. Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol. 2004. 287:L1178–85.

Kallapur SG., Presicce P., Rueda CM., Jobe AH., Chougnet CA. Fetal immune response to chorioamnionitis. Semin Reprod Med. 2014. 32:56–67.

Karasek M. Melatonin, human aging, and age-related diseases. Exp Gerontol. 2004. 39:1723–9.

Kim CJ., Romero R., Chaemsaithong P., Chaiyasit N., Yoon BH., Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015. 213:S29–52.

Lal CV., Xu X., Jackson P., Atkinson TP., Faye-Petersen OM., Kandasamy J, et al. Ureaplasma infection-mediated release of matrix metalloproteinase-9 and PGP: a novel mechanism of preterm rupture of membranes and chorioamnionitis. Pediatr Res. 2017. 81:75–9.

Lanoix D., Lacasse AA., Reiter RJ., Vaillancourt C. Melatonin: the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation–induced oxidative stress and apoptosis. Mol Cell Endocrinol. 2013. 381:35–45.

Lee JY., Li S., Shin NE., Na Q., Dong J., Jia B, et al. Melatonin for prevention of placental malperfusion and fetal compromise associated with intrauterine inflammation-induced oxidative stress in a mouse model. J Pineal Res. 2019a. 67:e12591.

Lee JY., Na Q., Shin N., Shin HE., Kang Y., Chudnovets A, et al. Melatonin for prevention of fetal lung injury associated with intrauterine inflammation and for lung maturation. J Pineal Res. 2020. 69:e12687.

Lee JY., Song H., Dash O., Park M., Shin NE., McLane MW, et al. Administration of melatonin for prevention of preterm birth and fetal brain injury associated with premature birth in a mouse model. Am J Reprod Immunol. 2019b. 82:e13151.

Lee MY., Kuan YH., Chen HY., Chen TY., Chen ST., Huang CC, et al. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J Pineal Res. 2007. 42:297–309.

Malpaux B., Migaud M., Tricoire H., Chemineau P. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J Biol Rhythms. 2001. 16:336–47.

Mauriz JL., Collado PS., Veneroso C., Reiter RJ., González-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res. 2013. 54:1–14.

McAdams RM., Juul SE. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int. 2012. 2012:561494.

McCarthy R., Jungheim ES., Fay JC., Bates K., Herzog ED., England SK. Riding the rhythm of melatonin through pregnancy to deliver on time. Front Endocrinol (Lausanne). 2019. 10:616.

Metzger RJ., Klein OD., Martin GR., Krasnow MA. The branching programme of mouse lung development. Nature. 2008. 453:745–50.

Mourani PM., Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr. 2013. 25:329–37.

Munshi UK., Niu JO., Siddiq MM., Parton LA. Elevation of inter-leukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol. 1997. 24:331–6.

Myatt L., Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004. 122:369–82.

Nakamura Y., Tamura H., Kashida S., Takayama H., Yamagata Y., Karube A, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001. 30:29–33.

Olegário JG., Silva MV., Machado JR., Rocha LP., Reis MA., Guimarães CS, et al. Pulmonary innate immune response and melatonin receptors in the perinatal stress. Clin Dev Immunol. 2013. 2013:340959.

Østensen M. Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol. 1998. 27:128–32.

Pan L., Fu JH., Xue XD., Xu W., Zhou P., Wei B. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr. 2009. 5:216–21.

Paredes SD., Korkmaz A., Manchester LC., Tan DX., Reiter RJ. Phytomelatonin: a review. J Exp Bot. 2008. 60:57–69.

Ray A., Ray S. Antibiotics prior to amniotomy for reducing infectious morbidity in mother and infant. Cochrane Database Syst Rev. 2014. (10):CD010626.

Rodrigues Helmo F., Etchebehere RM., Bernardes N., Meirelles MF., Galvão Petrini C., Penna Rocha L, et al. Melatonin treatment in fetal and neonatal diseases. Pathol Res Pract. 2018. 214:1940–51.

Romero R., Chaiworapongsa T., Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003. 133:1668S–1673S.

Romero R., Mazor M., Manogue K., Oyarzun E., Cerami A. Human decidua: a source of cachectin-tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol. 1991. 41:123–7.

Sagrillo-Fagundes L., Assunção Salustiano EM., Yen PW., Soliman A., Vaillancourt C. Melatonin in pregnancy: effects on brain development and CNS programming disorders. Curr Pharm Des. 2016. 22:978–86.

Sánchez A., Calpena AC., Clares B. Evaluating the oxidative stress in inflammation: role of melatonin. Int J Mol Sci. 2015. 16:16981–7004.

Song J., Kang SM., Lee KM., Lee JE. The protective effect of melatonin on neural stem cell against LPS-induced inflammation. Biomed Res Int. 2015. 2015:854359.

Stavsky M., Mor O., Mastrolia SA., Greenbaum S., Than NG., Erez O. Cerebral palsy—trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention. Front Pediatr. 2017. 5:21.

Stoll BJ., Hansen NI., Bell EF., Shankaran S., Laptook AR., Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010. 126:443–56.

Strijbis EMM., Oudman I., van Essen P., MacLennan AH. Cerebral palsy and the application of the International Criteria for Acute Intrapartum Hypoxia. Obstet Gynecol. 2006. 107:1357–65.

Sun FY., Lin X., Mao LZ., Ge WH., Zhang LM., Huang YL, et al. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. J Pineal Res. 2002. 33:48–56.

Tan DX., Manchester LC., Terron MP., Flores LJ., Reiter RJ. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res. 2007. 42:28–42.

Thibeault DW., Mabry SM., Ekekezie II., Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics. 2000. 106:1452–9.

Tomás-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res. 2005. 39:99–104.

Tricoire H., Locatelli A., Chemineau P., Malpaux B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology. 2002. 143:84–90.

Villamor-Martinez E., Álvarez-Fuente M., Ghazi AMT., Degraeuwe P., Zimmermann LJI., Kramer BW, et al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review, meta-analysis, and metaregression. JAMA Netw Open. 2019. 2:e1914611.

Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001. 50:553–62.

Watanabe K., Wakatsuki A., Shinohara K., Ikenoue N., Yokota K., Fukaya T. Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res. 2004. 37:276–80.

Welin AK., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res. 2007. 61:153–8.

Wenstrom KD., Andrews WW., Hauth JC., Goldenberg RL., Du-Bard MB., Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol. 1998. 178:546–50.

Wu YH., Zhou JN., Balesar R., Unmehopa U., Bao A., Jockers R, et al. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotrophin-releasing hormone. J Comp Neurol. 2006. 499:897–910.

Wu YW., Colford J., John M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000. 284:1417–24.

Yawno T., Castillo-Melendez M., Jenkin G., Wallace EM., Walker DW., Miller SL. Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev Neurosci. 2012. 34:543–51.

Yoon BH., Jun JK., Romero R., Park KH., Gomez R., Choi JH, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997a. 177:19–26.

Yoon BH., Kim CJ., Romero R., Jun JK., Park KH., Choi ST, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997b. 177:797–802.

Yoon BH., Romero R., Kim CJ., Koo JN., Choe G., Syn HC, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997c. 177:406–11.